Bio Green Med Solution Inc (BGMS)

• Market cap: $6.42M
• 1 day: -2.96%
• 5 days: -8.39%
• 1 month: 1.55%
• 3 months: -71.83%
• 6 months: -74.36%
• Year to date: -98.53%
• 1 year: -98.35%
• 5 years: -99.99%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.

Employees: 12